JP2007252645A - Transplanted ligament to be used for ligament reconstruction and method of animal ligament reconstruction - Google Patents

Transplanted ligament to be used for ligament reconstruction and method of animal ligament reconstruction Download PDF

Info

Publication number
JP2007252645A
JP2007252645A JP2006081389A JP2006081389A JP2007252645A JP 2007252645 A JP2007252645 A JP 2007252645A JP 2006081389 A JP2006081389 A JP 2006081389A JP 2006081389 A JP2006081389 A JP 2006081389A JP 2007252645 A JP2007252645 A JP 2007252645A
Authority
JP
Japan
Prior art keywords
ligament
graft
film
cells
main body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006081389A
Other languages
Japanese (ja)
Inventor
Yoshihiro Kishigami
義弘 岸上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2006081389A priority Critical patent/JP2007252645A/en
Publication of JP2007252645A publication Critical patent/JP2007252645A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a transplanted ligament applicable to a ligament reconstruction method capable of reducing a period of rehabilitation. <P>SOLUTION: The transplanted ligament 3 comprises a transplanted ligament main body 4 and a synovial fluid impermeable film 5 covering the main body 4. The synovial fluid opaque film 5 covers a part of the main body 4 coming in contact with the synovial fluid. For the transplanted ligament main body 4, a well-known artificial ligament or surrogate ligament is used. For the synovial fluid opaque film 5, a high-polymer film is used and a bioabsorbable film is especially preferable. In the case of high-polymer film, a method for covering is carried out only by winding it on the surface of the main body 4. The synovial fluid impermeable film 5 is also covered by applying high-polymer solution on the surface of the main body 4. For the high-polymer solution, bioabsorbable solution is preferable. When the surface of the main body 4 is covered with the film 5, the synovial fluid does not touch the main body 4. Thus, intrusion of a tissue into the main body 4 and engraftment can quickly be performed. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、損傷又は断裂した靭帯を再建する際に使用する移植靭帯に関するものである。また、この移植靭帯を使用した動物の靭帯再建方法に関するものである。   The present invention relates to a transplanted ligament used when a damaged or torn ligament is reconstructed. The present invention also relates to an animal ligament reconstruction method using the transplanted ligament.

サッカー、ラクビー、スキー、アメリカンフットボール、野球等の激しい運動を行うスポーツ選手は、膝、足首、肘等の関節部分の靭帯を損傷したり、断裂したりすることが多い。また、スポーツ選手だけではなく、通常人においても、靭帯を損傷したり断裂したりすることがある。このような場合、再びスポーツ選手として或いは社会人として復帰するためには、靭帯再建の手術及びリハビリを行うことになる。   Athletes who perform intense exercise such as soccer, rugby, skiing, American football, and baseball often damage or tear the ligaments of joints such as knees, ankles, and elbows. In addition, not only athletes but also normal people may damage or tear the ligaments. In such a case, in order to return again as an athlete or a member of society, surgery and rehabilitation for ligament reconstruction are performed.

靭帯再建の方法としては、人工靭帯を用いる方法と、自家筋膜又は自家靭帯等の代用靭帯を用いる方法がある。人工靭帯を用いる方法は、強度が高すぎたりして、自分の体に馴染みにくいということがあった。また、代用靭帯を用いる方法は、自分の体に馴染みやすいが、リハビリに1年以上かかり、スポーツ選手として復帰したり、社会復帰するのに時間がかかりすぎるということがあった。   As a ligament reconstruction method, there are a method using an artificial ligament and a method using a substitute ligament such as an autologous fascia or an autologous ligament. The method of using an artificial ligament has a problem that it is difficult to adapt to one's body because the strength is too high. In addition, although the method using the substitute ligament is easy to adjust to one's body, it takes one year or more for rehabilitation, and it takes too much time to return as an athlete or to return to society.

このため、代用靭帯を用いながら、リハビリ期間を短縮するための開発が種々行われている。たとえば、骨と接触する代用靭帯の部位にリン酸カルシウムをコーティングしておき、骨と代用靭帯の結合期間を短縮し、手術後からリハビリ開始までの期間を短縮化することが提案されている(非特許文献1)。すなわち、リハビリ開始までの期間を短縮化することにより、手術後から復帰までの期間を短縮化しようとするものである。   For this reason, various developments for shortening the rehabilitation period have been performed while using a substitute ligament. For example, it has been proposed that calcium phosphate is coated on the site of the substitute ligament that comes into contact with the bone, shortening the bond period between the bone and substitute ligament, and shortening the period from the start of surgery to the start of rehabilitation (non-patent) Reference 1). That is, by shortening the period until the start of rehabilitation, an attempt is made to shorten the period from surgery to return.

平成13年8月28日付け独立行政法人物質・材料研究機構発表「アパタイト系化合物を用いて靭帯・骨の直接結合に成功(靭帯再建のリハビリ期間を大幅に短縮)」Announced by National Institute for Materials Science, August 28, 2001 "Succeeded in direct bonding of ligament and bone using apatite compound (reduced rehabilitation period for ligament reconstruction)"

本発明者は、非特許文献1記載のように、骨と代用靭帯の結合期間に着目するのではなく、代用靭帯が靭帯様組織に置換するメカニズムに着目して、研究を進めていた。すなわち、靭帯様組織が生成されるメカニズムは、代用靭帯中に細胞が進入し、その細胞が生着し、分化し、整列することによって、靭帯様組織が生成されてゆくというものである。そこで、本発明者は、まず、動物実験を繰り返すことにより、代用靭帯中に、どの程度細胞が進入し生着してゆくものであるかを調査していた。この過程で、本発明者は、以下のような現象を発見した。   As described in Non-Patent Document 1, the present inventor did not pay attention to the joint period between bone and the substitute ligament, but focused on the mechanism by which the substitute ligament replaced the ligament-like tissue. That is, the mechanism by which a ligament-like tissue is generated is that cells enter the surrogate ligament, and the cells engraft, differentiate, and align, thereby generating a ligament-like tissue. Therefore, the present inventor first investigated the extent to which cells entered and engrafted into the substitute ligament by repeating animal experiments. In this process, the present inventor discovered the following phenomenon.

すなわち、代用靭帯4を用いて、図1に示す如く、第一骨1(前十字靭帯の場合は大腿骨)と第二骨2(前十字靭帯の場合は脛骨)を繋ぎ、手術後1ケ月経過後における代用靭帯4中の細胞数を測定したところ、後記比較例1で示すように、図1のaの部位では多数の細胞が存在しているのに、その他のb,c,d及びeの部位では、細胞数が非常に少ないという現象を発見した。   That is, as shown in FIG. 1, the substitute ligament 4 is used to connect the first bone 1 (the femur in the case of the anterior cruciate ligament) and the second bone 2 (the tibia in the case of the anterior cruciate ligament), and one month after the operation. When the number of cells in the surrogate ligament 4 after the lapse of time was measured, as shown in Comparative Example 1 described later, a large number of cells exist at the site a in FIG. 1, but the other b, c, d, and In the part of e, the phenomenon that the number of cells was very small was discovered.

本発明者は、何故に、aの部位では多数の細胞が存在しているのに、b〜eの部位では少数の細胞しか存在していないのかを検討した。この結果、aの部位では、代用靭帯4の一部が第一骨1中に埋入しているのに対して、b〜eの部位は第一骨1及び第二骨2中に埋入していないからではないかと考えた。そして、代用靭帯4が関節液に接触していると、細胞の代用靭帯4中への進入及び生着が阻害されるとの仮説を立てた。   The present inventor has examined why a large number of cells are present at the site a and only a small number of cells are present at the sites b to e. As a result, in the part a, a part of the substitute ligament 4 is embedded in the first bone 1, whereas the parts b to e are embedded in the first bone 1 and the second bone 2. I thought it was because I did not. Then, it was hypothesized that when the surrogate ligament 4 is in contact with the joint fluid, the entry and engraftment of cells into the surrogate ligament 4 is inhibited.

このような仮説が正しいか否かを検討するため、代用靭帯4のa〜eの部位を、関節液不透過性膜(具体的には水不透過性フィルム)5で被覆して、第一骨1及び第二骨2を繋ぎ、手術後1ケ月経過後における代用靭帯4中の細胞数を測定した。この結果、a〜eの部位で多数の細胞が存在していることが確認され(後記実施例1)、仮説が正しいことが証明された。本発明は、このような知見に基づいてなされたものである。   In order to examine whether or not such a hypothesis is correct, a site of a to e of the substitute ligament 4 is covered with a synovial fluid impermeable membrane (specifically, a water impermeable film) 5, and first The bone 1 and the second bone 2 were connected, and the number of cells in the substitute ligament 4 after one month after the operation was measured. As a result, it was confirmed that a large number of cells were present at sites a to e (Example 1 described later), and it was proved that the hypothesis was correct. The present invention has been made based on such knowledge.

すなわち、本発明は、少なくとも関節液に接触する部位の移植靭帯本体表面を、関節液不透過性膜で被覆したことを特徴とする靭帯再建に使用する移植靭帯に関するものである。また、この移植靭帯を用いて、動物の靭帯を再建する方法に関するものである。   That is, the present invention relates to a transplanted ligament used for ligament reconstruction, characterized in that at least a surface of a graft ligament body in contact with joint fluid is coated with a joint fluid-impermeable membrane. The present invention also relates to a method for reconstructing an animal ligament using the graft ligament.

本発明で使用する移植靭帯本体としては、自家筋膜、自家靭帯、他家の筋膜及び靭帯等の従来公知の代用靭帯が用いられる。また、代用靭帯だけではなく、人工靭帯を用いることも可能である。特に、コラーゲン製、ゼラチン製、シルク製又はポリ乳酸製等の生体吸収性の人工靭帯をも用いることができる。なお、生体吸収性の材料は、一般的に生分解性でもある。移植靭帯本体の長手方向の強度が弱い場合には、移植靭帯本体に高強度糸を付加するのが好ましい。たとえば、高強度糸7の周囲を移植靭帯本体4で囲繞した形態のものを使用するのが好ましい(図2)。また、高強度糸7と移植靭帯本体4とを引き揃えたものであってもよい。高強度糸としては、体液や水等を吸収しない疎水性のテフロン糸等が用いられる。   As the transplanted ligament body used in the present invention, conventionally known substitute ligaments such as autologous fascia, autologous ligament, fascia and ligament of other family are used. Further, not only a substitute ligament but also an artificial ligament can be used. In particular, bioabsorbable artificial ligaments such as collagen, gelatin, silk, or polylactic acid can also be used. Bioabsorbable materials are also generally biodegradable. When the strength in the longitudinal direction of the graft ligament body is weak, it is preferable to add a high-strength yarn to the graft ligament body. For example, it is preferable to use the one in which the periphery of the high-strength yarn 7 is surrounded by the graft ligament body 4 (FIG. 2). Alternatively, the high strength yarn 7 and the graft ligament body 4 may be aligned. As the high-strength yarn, a hydrophobic Teflon yarn that does not absorb body fluid, water or the like is used.

この移植靭帯本体を人に適用した場合、関節液に接触する部位の表面を、関節液不透過性膜で被覆する。被覆する部位は、関節液に接触する部位のみとして、その他の部位は被覆しなくてもよい。また、その他の部位をも関節液不透過性膜で被覆してもよい。関節液は、水分が主成分であって、その他の円滑成分等が含有されているものである。したがって、関節液不透過性膜としては、食品包装用フィルム等の高分子フィルムからなる水不透過性膜であれば、どのようなものでも採用することができる。   When this graft ligament body is applied to a person, the surface of the site that comes into contact with the joint fluid is covered with a joint fluid impermeable membrane. The part to be coated is limited to the part that comes into contact with the joint fluid, and other parts may not be covered. Other parts may also be covered with a synovial fluid impermeable membrane. The joint fluid is mainly composed of water and contains other smooth components. Therefore, any synovial fluid impermeable membrane can be used as long as it is a water impermeable membrane made of a polymer film such as a food packaging film.

移植靭帯本体の所定の部位を被覆する方法としては、以下のような方法が挙げられる。たとえば、関節液不透過性膜が高分子フィルムのような場合には、このフィルムを移植靭帯本体表面に巻回して被覆すればよい。また、フィルムと移植靭帯本体表面との接着力を向上させたいときには、接着剤で両者を接着させればよい。高分子フィルムとしては、天然高分子からなるフィルムや合成高分子からなるフィルムが用いられる。この中でも、特に、生体吸収性の高分子フィルムであるのが好ましい。すなわち、手術後リハビリ期間を経過し、靭帯が再建した際には、生体に吸収され消失するようなフィルムであるのが好ましい。このような生体吸収性の高分子フィルムとしては、コラーゲン製、ゼラチン製、シルク製、ポリ乳酸製の生分解性のものが挙げられる。また、接着剤としても任意のものが用いられるが、デンプン糊等の生体吸収性の接着剤を用いるのが好ましい。   Examples of a method for covering a predetermined site of the graft ligament body include the following methods. For example, when the synovial fluid impermeable membrane is a polymer film, the film may be wound around the surface of the graft ligament body to cover it. Moreover, what is necessary is just to adhere | attach both with an adhesive agent when improving the adhesive force of a film and the graft ligament main body surface. As the polymer film, a film made of a natural polymer or a film made of a synthetic polymer is used. Among these, a bioabsorbable polymer film is particularly preferable. That is, it is preferable that the film be absorbed by the living body and disappear when the ligament is reconstructed after the rehabilitation period after surgery. Examples of such bioabsorbable polymer films include biodegradable films made of collagen, gelatin, silk, and polylactic acid. Moreover, although arbitrary things are used also as an adhesive agent, it is preferable to use bioabsorbable adhesive agents, such as starch paste.

その他の被覆する方法としては、高分子溶液を移植靭帯本体表面の所定の部位に塗布し、乾燥して、移植靭帯本体表面にフィルム状物を形成してもよい。塗布方法としては、刷毛法やスプレー法等の公知の方法を採用することができる。高分子溶液としては、天然高分子又は合成高分子を溶解又は分散した溶液を用いることができる。この場合も、前記したような生体吸収性の高分子を用い、生体吸収性溶液として調整するのが好ましい。   As another coating method, a polymer solution may be applied to a predetermined site on the surface of the graft ligament body and dried to form a film-like material on the surface of the graft ligament body. As a coating method, a known method such as a brush method or a spray method can be employed. As the polymer solution, a solution in which a natural polymer or a synthetic polymer is dissolved or dispersed can be used. Also in this case, it is preferable to prepare a bioabsorbable solution using the bioabsorbable polymer as described above.

以上のようにして、関節液に接触する部位の移植靭帯本体表面が、関節液不透過性膜で被覆された移植靭帯が得られる。この移植靭帯を用いて、従来の人工靭帯又は代用靭帯を用いた場合と同様の手術方法で、人や動物に適用する。図3は、本発明に係る移植靭帯3を、手術によって人に適用した状態の模式図である。移植靭帯3は、第一骨1(大腿骨)と第二骨2(脛骨)とを繋ぎ、第一骨1及び第二骨2にボルト等で固定されている。本発明に係る移植靭帯3は、移植靭帯本体4と、要すれば移植靭帯本体4の強度を向上させるために付加された高強度糸7と、移植靭帯本体4の表面を被覆している関節液不透過性膜5とで構成されている。第一骨1と第二骨2の間は、関節液6で満たされている。そして、関節液6に接触している移植靭帯3の部位表面は、関節液不透過性膜5で被覆されている。したがって、関節液6は、移植靭帯本体4には接触せず、骨(具体的には骨髄)からの本体4中への細胞の進入及び生着を阻害しないのである。なお、細胞は骨髄から供給されるため、骨と移植靭帯本体4とは直接接触しているのが好ましい。したがって、移植靭帯本体4の両端は、関節液不透過性膜5で被覆されていない方が、好ましい。   As described above, a graft ligament in which the surface of the graft ligament main body in contact with the joint fluid is coated with the joint fluid impermeable membrane is obtained. Using this transplanted ligament, it is applied to humans and animals by the same surgical method as when a conventional artificial ligament or a substitute ligament is used. FIG. 3 is a schematic view of a state in which the graft ligament 3 according to the present invention is applied to a person by surgery. The graft ligament 3 connects the first bone 1 (femur) and the second bone 2 (tibia), and is fixed to the first bone 1 and the second bone 2 with bolts or the like. The graft ligament 3 according to the present invention includes a graft ligament body 4, a high-strength yarn 7 added to improve the strength of the graft ligament body 4, and a joint covering the surface of the graft ligament body 4. It is comprised with the liquid impervious film | membrane 5. The space between the first bone 1 and the second bone 2 is filled with the joint fluid 6. The surface of the site of the graft ligament 3 that is in contact with the joint fluid 6 is covered with the joint fluid impermeable membrane 5. Therefore, the joint fluid 6 does not contact the graft ligament body 4 and does not inhibit the entry and engraftment of cells from the bone (specifically, bone marrow) into the body 4. Since cells are supplied from the bone marrow, the bone and the graft ligament body 4 are preferably in direct contact. Therefore, it is preferable that both ends of the graft ligament body 4 are not covered with the joint fluid impermeable membrane 5.

移植靭帯3は、手術時に作成してもよい。たとえば、手術時において、移植靭帯本体4(又は高強度糸7が付加された移植靭帯本体4)と関節液不透過性膜5とを準備しておき、該当箇所(膝)を切開した後、関節液6が接触する寸法を確認し、この寸法に合わせて、関節液不透過性膜5を移植靭帯本体4の関節液6が接触する部位表面に被覆してもよい。そして、その後、移植靭帯3を靭帯損傷断裂部に固定してもよい。また、移植靭帯本体4(又は高強度糸7が付加された移植靭帯本体4)を、靭帯損傷断裂部に固定した後、第一骨1と第二骨2の間の本体4の部位(すなわち、関節液6が接触する部位)を、関節液不透過性膜5で巻回して被覆してもよい。   The graft ligament 3 may be created at the time of surgery. For example, at the time of surgery, after preparing the graft ligament body 4 (or the graft ligament body 4 to which the high-strength thread 7 is added) and the synovial fluid impermeable membrane 5 and incising the corresponding part (knee), The dimension in which the joint fluid 6 contacts is confirmed, and the surface of the site of the graft ligament body 4 in contact with the joint fluid 6 may be coated with the joint fluid impermeable membrane 5 in accordance with this dimension. And after that, you may fix the graft ligament 3 to a ligament damage tear part. Further, after fixing the graft ligament body 4 (or the graft ligament body 4 to which the high-strength yarn 7 is added) to the ligament injury rupture portion, the region of the body 4 between the first bone 1 and the second bone 2 (that is, The part where the synovial fluid 6 contacts may be covered with the synovial fluid impermeable membrane 5 and covered.

本発明に係る移植靭帯は、人又は動物に対して適用しうる。動物の中でも、犬は介助犬等として、障害者にとってはかけがえのないものである。したがって、本発明に係る移植靭帯、及びこの移植靭帯を用いた靭帯再建方法は、犬に適用して有益である。   The transplant ligament according to the present invention can be applied to humans or animals. Among animals, dogs are irreplaceable for disabled people as service dogs. Therefore, the graft ligament according to the present invention and the ligament reconstruction method using the graft ligament are beneficial when applied to a dog.

本発明に係る移植靭帯は、代用靭帯等の移植靭帯本体表面が関節液不透過性膜で被覆されてなる。そして、被覆箇所は、少なくとも関節液に接触する部位である。したがって、本発明に係る移植靭帯を人又は動物に適用して、靭帯再建を行うと、移植靭帯本体には関節液が接触しないことになる。これによって、骨(骨髄)から移植靭帯本体に供給される細胞が、関節液に接触せず、その進入及び生着を阻害することが少ない。この結果、移植靭帯本体は、自家細胞による靭帯様組織に早期に置換されることになる。   The graft ligament according to the present invention is formed by coating the surface of a graft ligament body such as a substitute ligament with a synovial fluid impermeable membrane. And a covering location is a site | part which contacts at least joint fluid. Therefore, when the graft ligament according to the present invention is applied to a human or an animal and ligament reconstruction is performed, the joint fluid does not come into contact with the graft ligament body. As a result, cells supplied from the bone (bone marrow) to the graft ligament body do not come into contact with the joint fluid and rarely inhibit its entry and engraftment. As a result, the transplanted ligament body is quickly replaced with a ligament-like tissue by autologous cells.

以上のことから、本発明に係る移植靭帯を用いて靭帯再建を行えば、靭帯再建のリハビリ期間が短くなり、早期にスポーツに復帰することができ、また、早期に社会復帰しうるという効果を奏するものである。   From the above, if the ligament reconstruction is performed using the transplanted ligament according to the present invention, the rehabilitation period of the ligament reconstruction is shortened, the sport can be returned to early, and the effect of being able to return to society early. It is what you play.

以下、実施例に基づき本発明を説明するが、本発明は実施例に限定されるものではない。本発明は、移植靭帯本体が関節液に接触していると、細胞の移植靭帯本体中への進入及び生着が阻害されるとの知見に基づき、移植靭帯本体が関節液に接触しないように工夫を施したものとして、解釈されるべきである。   EXAMPLES Hereinafter, although this invention is demonstrated based on an Example, this invention is not limited to an Example. The present invention is based on the knowledge that when the graft ligament body is in contact with the synovial fluid, the entry and engraftment of cells into the graft ligament body is inhibited, so that the graft ligament body does not contact the synovial fluid. It should be interpreted as something that has been devised.

比較例1
患犬:ビーグル 2才 雄 実験犬
患部:左後肢 膝前十字靭帯
移植靭帯:左側アキレス腱の縦切開された半分(自家靭帯)を、移植靭帯本体として使 用した。そして、強度向上のため、テフロン糸を付加し、図2の状態とした移植 靭帯を使用した。なお、移植靭帯本体の長手方向長さは40mmとした。
Comparative Example 1
Patient dog: Beagle 2 years old Male Experimental dog Affected part: Left hind limb Knee cruciate ligament Transplant ligament: The half of the left Achilles tendon (autologous ligament) was used as the graft ligament body. Then, in order to improve the strength, a graft ligament in which Teflon yarn was added and the state shown in FIG. 2 was used was used. The longitudinal length of the graft ligament body was 40 mm.

患部の膝前十字靭帯を全摘出した後、この部位を移植靭帯で置換して、図3のような状態(但し、関節液不透過性膜5は無し。)で固定して、靭帯再建を行った。手術後、膝関節の可動域を調節できるトーマ固定枠を用いて運動制限した。初めの1週間は完全固定とし、その後1ケ月かけて、徐々に可動域を拡大していった。そして、1ケ月間経過後、患部を切開し、図1に示したa〜eの各部位から、検体を採取し、細胞数を測定した。この細胞数は、電子顕微鏡写真で測定した。その結果は、図4に示したとおり、aの部位では、約50000個/mm2の細胞数であったが、b〜eの各部位では、10000個/mm2未満の細胞数となっていた。 After completely removing the anterior cruciate ligament of the affected area, this site is replaced with a transplanted ligament and fixed in the state as shown in FIG. 3 (however, the synovial fluid impermeable membrane 5 is not present). went. After the operation, the movement was restricted using a toma fixed frame that can adjust the range of motion of the knee joint. The first week was completely fixed, and then the range of motion was gradually expanded over a month. Then, after 1 month, the affected part was incised, specimens were collected from each site a to e shown in FIG. 1, and the number of cells was measured. The number of cells was measured with an electron micrograph. As a result, as shown in FIG. 4, the number of cells was about 50,000 cells / mm 2 at the site a, but the number of cells was less than 10,000 cells / mm 2 at the sites b to e. It was.

実施例1
患犬:ビーグル 2才 雌 実験犬
患部:左後肢 膝前十字靭帯
移植靭帯:比較例1で使用したものと同様のものを使用した。そして、移植靭帯本体の 両端を10mmずつ残して、中央部20mmをポリエチレン製フィルム(厚さ20 μm)よりなる関節液不透過性膜で巻回して被覆したものを使用した。
Example 1
Patient dog: Beagle 2 years old Female Experimental dog Affected part: Left hind limb Knee cruciate ligament Transplant ligament: The same one as used in Comparative Example 1 was used. Then, the both ends of the graft ligament body were left 10 mm each, and the center part 20 mm was covered with a joint fluid impermeable film made of a polyethylene film (thickness 20 μm).

患部の膝前十字靭帯を全摘出した後、この部位を移植靭帯で置換して、図3のような状態で固定して、靭帯再建を行った。手術後、膝関節の可動域を調節できるトーマ固定枠を用いて運動制限した。初めの1週間は完全固定とし、その後1ケ月かけて、徐々に可動域を拡大していった。そして、1ケ月間経過後、患部を切開し、図1に示したa〜eの各部位から、検体を採取し、細胞数を測定した。この細胞数は、電子顕微鏡写真で測定した。その結果は、図4に示したとおり、各部位共に、40000個/mm2以上の細胞数となっており、速やかに細胞が進入し生着していることが分かった。 After removing the entire anterior cruciate ligament of the affected area, this site was replaced with a transplanted ligament and fixed in the state shown in FIG. 3 to perform ligament reconstruction. After the operation, the movement was restricted using a toma fixed frame that can adjust the range of motion of the knee joint. The first week was completely fixed, and then the range of motion gradually expanded over a month. Then, after 1 month, the affected part was incised, specimens were collected from each site a to e shown in FIG. 1, and the number of cells was measured. The number of cells was measured with an electron micrograph. As a result, as shown in FIG. 4, the number of cells was 40000 cells / mm 2 or more at each site, and it was found that cells rapidly entered and were engrafted.

比較例2
患犬:ビーグル 2.5才 雌 実験犬
患部:左後肢 膝前十字靭帯
移植靭帯:比較例1で使用したものと同様のものを使用した。
Comparative Example 2
Patient dog: Beagle 2.5 years old Female Experimental dog Affected part: Left hind limb Knee cruciate ligament Transplant ligament: The same one as used in Comparative Example 1 was used.

患部の膝前十字靭帯を全摘出した後、この部位を移植靭帯で置換して、図3のような状態(但し、関節液不透過性膜5は無し。)で固定して、靭帯再建を行った。手術後、膝関節の可動域を調節できるトーマ固定枠を用いて運動制限した。初めの1週間は完全固定とし、その後20日かけて、徐々に可動域を拡大していった。そして、20日間経過後、患部を切開し、図1に示したbの部位から、検体を採取し、細胞数を測定した。この細胞数は、電子顕微鏡写真で測定した。その結果は、図5に示したとおり、10000個/mm2未満の細胞数となっていた。 After completely removing the anterior cruciate ligament of the affected area, this site is replaced with a transplanted ligament and fixed in the state as shown in FIG. 3 (however, the synovial fluid impermeable membrane 5 is not present). went. After the operation, the movement was restricted using a toma fixed frame that can adjust the range of motion of the knee joint. The first week was completely fixed, and the range of motion gradually expanded over the next 20 days. After the lapse of 20 days, the affected part was incised, a specimen was collected from the site b shown in FIG. 1, and the number of cells was measured. The number of cells was measured with an electron micrograph. As a result, as shown in FIG. 5, the number of cells was less than 10,000 cells / mm 2 .

その後、再び患部を縫合し、さらに20日間(合計で40日間)リハビリを行った。そして、再び患部を切開し、図1に示したbの部位から、検体を採取し、細胞数を測定した。その結果は、図5に示したとおり、10000個/mm2未満の細胞数となっていた。さらに同様の実験を20日間毎に繰り返し行い、合計で60日間及び80日間のリハビリ後における細胞数を測定した。この結果は、いずれも図5に示したとおり、10000個/mm2未満の細胞数であった。 Thereafter, the affected area was sutured again and rehabilitation was performed for another 20 days (40 days in total). Then, the affected part was incised again, a specimen was collected from the site b shown in FIG. 1, and the number of cells was measured. As a result, as shown in FIG. 5, the number of cells was less than 10,000 cells / mm 2 . Furthermore, the same experiment was repeated every 20 days, and the number of cells after rehabilitation for 60 days and 80 days in total was measured. As a result, as shown in FIG. 5, the number of cells was less than 10,000 cells / mm 2 .

実施例2
患犬:ビーグル 3才 雌 実験犬
患部:左後肢 膝前十字靭帯
移植靭帯:比較例1で使用したものと同様のものを使用した。そして、移植靭帯本体の 両端を10mmずつ残して、中央部20mmをポリエチレン製フィルム(厚さ20 μm)よりなる関節液不透過性膜で巻回して被覆したものを使用した。
Example 2
Patient dog: Beagle 3 years old Female Experimental dog Affected part: left hind limb Knee cruciate ligament Transplant ligament: The same one as used in Comparative Example 1 was used. Then, the both ends of the graft ligament body were left 10 mm each, and the center part 20 mm was covered with a joint fluid impermeable film made of a polyethylene film (thickness 20 μm).

患部の膝前十字靭帯を全摘出した後、この部位を移植靭帯で置換して、図3のような状態で固定して、靭帯再建を行った。手術後、膝関節の可動域を調節できるトーマ固定枠を用いて運動制限した。初めの1週間は完全固定とし、その後20日かけて、徐々に可動域を拡大していった。そして、20日間経過後、患部を切開し、図1に示したbの部位から、検体を採取し、細胞数を測定した。この細胞数は、電子顕微鏡写真で測定した。その結果は、図5に示したとおり、10000個/mm2以上の細胞数となっていた。なお、検体の採取の際、関節液不透過性膜に孔が開くが、この孔にデンプン糊を付着させて、孔を塞いだ。 After removing the entire anterior cruciate ligament of the affected area, this site was replaced with a transplanted ligament and fixed in the state shown in FIG. 3 to perform ligament reconstruction. After the operation, the movement was restricted using a toma fixed frame that can adjust the range of motion of the knee joint. The first week was completely fixed, and the range of motion gradually expanded over the next 20 days. After the lapse of 20 days, the affected part was incised, a specimen was collected from the site b shown in FIG. 1, and the number of cells was measured. The number of cells was measured with an electron micrograph. As a result, as shown in FIG. 5, the number of cells was 10,000 cells / mm 2 or more. When the specimen was collected, a hole was opened in the synovial fluid impermeable membrane, and starch was adhered to the hole to close the hole.

比較例2と同様にして、再び患部を縫合し、さらに20日間(合計で40日間)リハビリを行った。そして、再び患部を切開し、図1に示したbの部位から、検体を採取し、細胞数を測定した。その結果は、図5に示したとおり、30000個/mm2以上の細胞数となっていた。このときも、関節液不透過性膜に孔が開くが、この孔にデンプン糊を付着させて、孔を塞いだ。さらに同様の実験を20日間毎に繰り返し行い、合計で60日間及び80日間のリハビリ後における細胞数を測定した。この結果は、いずれも図5に示したとおり、40000個/mm2以上の細胞数であった。 In the same manner as in Comparative Example 2, the affected area was sutured again, and rehabilitation was further performed for 20 days (40 days in total). Then, the affected part was incised again, a specimen was collected from the site b shown in FIG. 1, and the number of cells was measured. As a result, as shown in FIG. 5, the number of cells was 30000 cells / mm 2 or more. At this time, a hole opened in the synovial fluid impermeable membrane, and starch paste was attached to the hole to close the hole. Furthermore, the same experiment was repeated every 20 days, and the number of cells after rehabilitation for 60 days and 80 days in total was measured. As a result, as shown in FIG. 5, the number of cells was 40000 cells / mm 2 or more.

従来の代用靭帯で大腿骨と脛骨とを繋いだ状態の模式図である。It is a schematic diagram of the state which connected the femur and the tibia with the conventional substitute ligament. 本発明に係る移植靭帯本体に高強度糸を付加した例を示した模式的斜視図である。It is the typical perspective view which showed the example which added the high strength thread | yarn to the graft ligament main body which concerns on this invention. 本発明の一例に係る移植靭帯で、前十字靭帯の再建手術を行った後の模式図である。It is a schematic diagram after performing the reconstruction operation of the anterior cruciate ligament in the graft ligament according to an example of the present invention. 比較例1及び実施例1による靭帯再建法で、靭帯a〜eの部位における1ケ月経過後の細胞数を表したグラフである。It is the graph showing the cell number after one month progress in the site | part of ligament ae by the ligament reconstruction method by the comparative example 1 and Example 1. FIG. 比較例2及び実施例2による靭帯再建法で、靭帯bの部位における20〜80日経過後の細胞数を表したグラフである。It is the graph showing the cell number after 20-80 days progress in the site | part of the ligament b by the ligament reconstruction method by the comparative example 2 and Example 2. FIG.

符号の説明Explanation of symbols

1 第一骨(大腿骨)
2 第二骨(脛骨)
3 移植靭帯
4 移植靭帯本体
5 関節液不透過性膜
6 関節液
7 高強度糸
1 First bone (femur)
2 Second bone (tibia)
3 graft ligament 4 graft ligament body 5 synovial fluid impermeable membrane 6 joint fluid 7 high strength thread

Claims (9)

少なくとも関節液に接触する部位の移植靭帯本体表面を、関節液不透過性膜で被覆したことを特徴とする靭帯再建に使用する移植靭帯。   A graft ligament for use in ligament reconstruction, characterized in that at least the surface of a graft ligament body in contact with joint fluid is coated with a joint fluid impermeable membrane. 関節液に接触しない部位には、関節液不透過性膜が被覆されていない請求項1記載の靭帯再建に使用する移植靭帯。   The transplanted ligament for use in ligament reconstruction according to claim 1, wherein a portion that does not come into contact with joint fluid is not covered with a synovial fluid impermeable membrane. 移植靭帯本体が、人工靭帯又は代用靭帯である請求項1記載の靭帯再建に使用する移植靭帯。   The graft ligament used for ligament reconstruction according to claim 1, wherein the graft ligament body is an artificial ligament or a substitute ligament. 関節液不透過性膜として、高分子フィルムを用いた請求項1記載の靭帯再建に使用する移植靭帯。   The graft ligament used for ligament reconstruction according to claim 1, wherein a polymer film is used as the synovial fluid impermeable membrane. 高分子フィルムが、生体吸収性フィルムである請求項4記載の靭帯再建に使用する移植靭帯。   The graft ligament used for ligament reconstruction according to claim 4, wherein the polymer film is a bioabsorbable film. 高分子溶液を、移植靭帯本体表面に塗布することにより、関節液不透過性膜を形成した請求項1記載の靭帯再建に使用する移植靭帯。   The graft ligament used for ligament reconstruction according to claim 1, wherein a synovial fluid impermeable film is formed by applying a polymer solution to the surface of the graft ligament body. 高分子溶液が、生体吸収性溶液である請求項6記載の靭帯再建に使用する移植靭帯。   The graft ligament used for ligament reconstruction according to claim 6, wherein the polymer solution is a bioabsorbable solution. 移植靭帯と関節液不透過性膜とを準備した後、該移植靭帯の少なくとも関節液に接触する部位表面を、該関節液不透過性膜で被覆して、動物の靭帯損傷断裂部に固定することを特徴とする動物の靭帯再建方法。   After preparing the graft ligament and the joint fluid impermeable membrane, at least the surface of the graft ligament that contacts the joint fluid is coated with the joint fluid impermeable membrane and fixed to the ligament injury rupture part of the animal An animal ligament reconstruction method characterized by the above. 動物が犬である請求項8記載の動物の靭帯再建方法。   The animal ligament reconstruction method according to claim 8, wherein the animal is a dog.
JP2006081389A 2006-03-23 2006-03-23 Transplanted ligament to be used for ligament reconstruction and method of animal ligament reconstruction Pending JP2007252645A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006081389A JP2007252645A (en) 2006-03-23 2006-03-23 Transplanted ligament to be used for ligament reconstruction and method of animal ligament reconstruction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006081389A JP2007252645A (en) 2006-03-23 2006-03-23 Transplanted ligament to be used for ligament reconstruction and method of animal ligament reconstruction

Publications (1)

Publication Number Publication Date
JP2007252645A true JP2007252645A (en) 2007-10-04

Family

ID=38627481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006081389A Pending JP2007252645A (en) 2006-03-23 2006-03-23 Transplanted ligament to be used for ligament reconstruction and method of animal ligament reconstruction

Country Status (1)

Country Link
JP (1) JP2007252645A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7458308B2 (en) 2020-12-10 2024-03-29 眞介 石井 Hip prosthesis system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7458308B2 (en) 2020-12-10 2024-03-29 眞介 石井 Hip prosthesis system

Similar Documents

Publication Publication Date Title
US11076845B2 (en) Methods and procedures for ligament repair
AU2017291837B2 (en) Indirect method of articular tissue repair
Yeung et al. Pulsed ultrasound treatment accelerates the repair of Achilles tendon rupture in rats
JP6494747B2 (en) Soft tissue repair matrix and manufacturing method thereof.
Ohtera et al. Effects of periosteum wrapped around tendon in a bone tunnel: a biomechanical and histological study in rabbits
Higuchi et al. Efficacy of β-tricalcium phosphate graft into the bone defects after bone-patellar tendon-bone anterior cruciate ligament reconstruction
JP2007252645A (en) Transplanted ligament to be used for ligament reconstruction and method of animal ligament reconstruction
Biskup et al. Intra-articular repair for cranial cruciate ligament rupture in the dog
RU2440057C1 (en) Method of heteroplastic transplantation of finger flexor tendon
US8652207B2 (en) Plug components for bone tunnel
Poonnoose et al. Chronic rupture of the extensor apparatus of the knee joint
De Rooster Cranial cruciate ligament disease in the dog: contributions to etiology, diagnosis and treatment
RU2716450C1 (en) Method for patellar ligament length restoration
Hoehmann Anterior cruciate ligament injury: A consideration for internal brace ligament augmentation
RU2266718C2 (en) Method for restoring direct ligament of canine knee cap
RU2233643C2 (en) Method for carrying out plasty of posterior cruciate ligament of knee joint
Kim The development of biodegradable metallic screws and suture anchors for soft tissue fixation in orthopaedic surgery
Piontek et al. Biomaterials in Meniscus Repair
Gaonkar et al. Reconstruction of th tendon with peroneu
Zhao et al. Application of different biomaterials in Achilles tendon repair for exercise injury
RU2546091C1 (en) Method of treating shin soft tissue defects
YAMADA et al. Bone-Demineralized bone-Bone Grafts for Ligament Reconstruction
Laflamme et al. Biotextiles as medical implants: 20. Anterior cruciate ligament prostheses using biotextiles